...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: OTC Expert & Grey Market Restrictions

 No apologies necessary. That note is confusing AF.

I'm happy with my holdings as is, so I guess we'll see.

Wonder if that note is what caused the trading activity today though, lol

Share
New Message
Please login to post a reply